abstract |
A novel use of chloride channel openers, in particular prostaglandin compounds, for the treatment of abdominal discomfort is disclosed. In addition, new uses of chloride channel openers, in particular prostaglandin compounds, for the treatment of functional gastrointestinal disorders are disclosed. |